Chief Strategy Officer
CurrentEnsuring that the Cell and Gene Therapy Catapult stays at the forefront of building a vibrant Advanced Therapy Medicinal Product (ATMP) market in the UK. Uniquely engaging across academia, industry and UK Government to support the discovery, development and manufacture of effective treatments for rare and complex diseases.